The company’s R&D strengths are in developing intellectual property in non-infringing processes and resolving complex formulation challenges. Elixir Research is in the process of developing new drug delivery systems, new dosage formulations, and applying new technology for better processes.
The Centre meets CGLP requirements, and is focused on the areas of Pharmaceutical development for generics and new chemical entities, analytical research and novel drug delivery systems.